CANDRIAM S.C.A. – Bristol-Myers Squibb Company Transaction History
CANDRIAM S.C.A. portfolio value:
$31.36M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
-7.68%
quarter
Bristol-Myers Squibb Company 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +62.46% | 169.59K shares | 10.45M | $71.09 | 441.11K |
Q2 2022 | share | Decrease | -2.43% | -6.75K shares | 585K | $77 | 271.51K |
Q1 2022 | share | Decrease | -9.82% | -30.31K shares | 1.08M | $73.03 | 278.27K |
Q4 2021 | share | Decrease | -18.99% | -72.35K shares | -3.29M | $62.52 | 308.59K |
Q3 2021 | share | Decrease | -4.62% | -18.43K shares | -4.14M | $59.17 | 380.95K |
Q2 2021 | share | Decrease | -77.62% | -1.38M shares | -79.65M | $65.79 | 399.38K |
Q1 2021 | share | Decrease | -0.01% | -94 shares | -4.37M | $62.15 | 1.78M |
Q4 2020 | share | Increase | +5.33% | 90.35K shares | 8.56M | $60.6 | 1.78M |
Q3 2020 | share | Increase | +12.59% | 189.48K shares | 13.65M | $58 | 1.69M |
Q2 2020 | share | Decrease | -39.77% | -993.76K shares | -68.29M | $56.14 | 1.50M |
Q1 2020 | share | Increase | +0.01% | 156 shares | -3.59M | $52.79 | 2.49M |
Q4 2019 | share | Decrease | -4.67% | -122.36K shares | 27.47M | $60.36 | 2.49M |
Q3 2019 | share | Increase | +7.95% | 193.12K shares | 23.29M | $47.3 | 2.62M |
Q2 2019 | share | Increase | +23.04% | 454.64K shares | 15.47M | $41.93 | 2.42M |
Q1 2019 | share | Increase | +44.82% | 610.73K shares | 23.32M | $43.73 | 1.97M |
Q4 2018 | share | Increase | +32.72% | 335.86K shares | 7.08M | $47.21 | 1.36M |
Q3 2018 | share | Increase | +7.10% | 68.09K shares | 10.68M | $56.02 | 1.02M |
Q2 2018 | share | Increase | +130.83% | 543.28K shares | 26.78M | $49.59 | 958.54K |
Q1 2018 | share | Decrease | -6.94% | -30.94K shares | -1.07M | $56.31 | 415.26K |
Q4 2017 | share | Decrease | -28.40% | -176.98K shares | -12.37M | $54.21 | 446.20K |
Q3 2017 | share | Increase | +155.83% | 379.59K shares | 26.14M | $56.04 | 623.19K |
Q2 2017 | share | Decrease | -14.57% | -41.54K shares | -1.93M | $48.65 | 243.59K |
Q1 2017 | share | Decrease | -37.97% | -174.56K shares | -11.35M | $47.14 | 285.14K |
Q4 2016 | share | Decrease | -15.31% | -83.13K shares | -2.40M | $50.32 | 459.71K |
Q3 2016 | share | Increase | +36.27% | 144.48K shares | -31K | $46.11 | 542.84K |
Q2 2016 | share | Decrease | -6.72% | -28.69K shares | 2.16M | $62.9 | 398.36K |
Q1 2016 | share | Increase | +79.84% | 189.58K shares | 10.79M | $54.35 | 427.05K |